EBO.AX · ASX · Healthcare
EBOS Group Limited
Also onShortfallConsensus DriftCrosscheck
Implied value per share
AUD 37.80
Market price
AUD 15.92
Implied upside
+137.4%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (AUD). Outflows negative.
| Line | FY27 | FY28 | FY29 | FY30 | FY31 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | AUD 17.6bn | AUD 18.9bn | AUD 20.2bn | AUD 21.7bn | AUD 23.2bn | +7.2% |
| EBIT | AUD 600.3m | AUD 643.5m | AUD 689.9m | AUD 739.6m | AUD 792.8m | +7.2% |
| NOPAT | AUD 428.2m | AUD 459.1m | AUD 492.1m | AUD 527.6m | AUD 565.6m | +7.2% |
| Add depreciation & amortisation | AUD 199.2m | AUD 213.5m | AUD 228.9m | AUD 245.4m | AUD 263.1m | +7.2% |
| Less capital expenditure | AUD -199.2m | AUD -213.5m | AUD -228.9m | AUD -245.4m | AUD -263.1m | +7.2% |
| Less increase in working capital | AUD -71.8m | AUD -77.0m | AUD -82.6m | AUD -88.5m | AUD -94.9m | +7.2% |
| Free cashflow to firm | AUD 356.4m | AUD 382.1m | AUD 409.6m | AUD 439.1m | AUD 470.7m | +7.2% |
| Discount factor | 0.9696 | 0.9116 | 0.8571 | 0.8058 | 0.7576 | - |
| Present value | AUD 345.6m | AUD 348.3m | AUD 351.0m | AUD 353.8m | AUD 356.6m | +0.8% |
| Present Value Of The Forecast | AUD 1.8bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.35% | Australian Government 10-year (RBA F2) |
| Equity risk premium | 6.00% | Market assumption |
| Beta | 0.428 | Reported 0.146, pulled toward 1.0 (Blume) |
| Cost of equity | 7.91% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.81% | Interest expense / average total debt |
| Market capitalisation | AUD 3.3bn | 58.8% of capital |
| Total debt | AUD 2.3bn | 41.2% of capital, book value as a proxy |
| Tax rate | 28.7% | Effective, capped at statutory |
| WACC | 6.36% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
82% of EV
- Forecast FCFF, final year
- AUD 470.7m
- Capex at depreciation, working capital in reinvestment
- AUD 565.6m
- Less reinvestment at g/ROIC (29.1% of NOPAT)
- AUD -164.5m
- Capitalised
- AUD 401.1m
- ROIC (reported)
- 8.6%
- Terminal value, undiscounted
- AUD 10.6bn
- Terminal value, discounted
- AUD 8.1bn
- Enterprise value
- AUD 9.8bn
- Less net debt
- AUD 2.0bn
- Equity value
- AUD 7.8bn
Exit at 7.8x EBITDA
78% of EV
- Terminal value, undiscounted
- AUD 8.3bn
- Terminal value, discounted
- AUD 6.3bn
- Enterprise value
- AUD 8.0bn
- Less net debt
- AUD 2.0bn
- Equity value
- AUD 6.0bn
Spread between methods: 26%.
Sensitivity
Value per share (AUD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.36% | 65.32 | 74.04 | 87.36 | 110.36 | 159.85 |
| 5.36% | 45.92 | 49.35 | 53.93 | 60.40 | 70.27 |
| 6.36% | 34.51 | 35.98 | 37.80 | 40.13 | 43.22 |
| 7.36% | 26.98 | 27.59 | 28.29 | 29.13 | 30.15 |
| 8.36% | 21.66 | 21.83 | 22.02 | 22.22 | 22.44 |
Outlined: this model. Green text: above today's price of 15.92. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 7.2% | -8.5% | -15.7pp |
| EBIT margin | 3.4% | 1.9% | -1.5pp |
| Discount rate | 6.4% | 10.2% | +3.8pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.